000 01363 a2200373 4500
005 20250517135513.0
264 0 _c20190416
008 201904s 0 0 eng d
022 _a1522-1709
024 7 _a10.1007/s11325-017-1459-8
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCostalat, Guillaume
245 0 0 _aIntermittent hypoxia revisited: a promising non-pharmaceutical strategy to reduce cardio-metabolic risk factors?
_h[electronic resource]
260 _bSleep & breathing = Schlaf & Atmung
_c03 2018
300 _a267-271 p.
_bdigital
500 _aPublication Type: Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aCardiovascular Diseases
_xetiology
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aHypoxia
_xcomplications
650 0 4 _aMale
650 0 4 _aMetabolic Diseases
_xetiology
650 0 4 _aMiddle Aged
650 0 4 _aObesity
_xcomplications
650 0 4 _aOverweight
_xcomplications
650 0 4 _aOxygen
_xadministration & dosage
650 0 4 _aRisk Factors
650 0 4 _aSingle-Blind Method
700 1 _aLemaitre, Frederic
700 1 _aTobin, Barbara
700 1 _aRenshaw, Gillian
773 0 _tSleep & breathing = Schlaf & Atmung
_gvol. 22
_gno. 1
_gp. 267-271
856 4 0 _uhttps://doi.org/10.1007/s11325-017-1459-8
_zAvailable from publisher's website
999 _c26845445
_d26845445